China Resources Pharmaceutical (03320.HK): Boya Bioscience (300294.SZ) reported a net profit attributable to shareholders of 225 million yuan in the first half of the year, a decrease of 28.68% year-on-year.

Zhijun Finance APP News, China Resources Pharmaceuticals (03320.HK) announced the performance of its subsidiary, China Resources Biopharmaceutical Co., Ltd. (300294.SZ) for the six months ending June 30, 2025. The total revenue was 1.008 billion RMB, an increase of 12.51% year-on-year; the net profit attributable to shareholders was 225 million RMB, a decrease of 28.68% year-on-year.